The juvenile laryngeal papillomatosis is the most frequent benign tumour of the larynx.
In Sir Morrel MacKenzie describes papillomas as pharyngo-laryngeal lesions at papillomas larynx child, and the term of juvenile laryngeal papillomatosis has been introduced by Chevalier Jakson in The etiological agent is HPV types 6 and 11 and the section of the respiratory tract the most frequently infected is the squamocolumelar junction. Juvenile laryngeal papillomatosis is a disease more frequent between 3 and 5 years, leac pentru oxiuri by multiple relapses and exuberant papillomas larynx at the level of the laryngeal mucosa.
The annual costs of the treatment of this papillomas larynx are over million USD. The evolution of the disease decreases the quality of the life of the patient and malignancy and death can occur during the disease.
Objectives: bringing new informations about the etiology, the diagnosis and the treatment of the disease for the specialties that deal with this pathology, especially paediatrics and papillomas larynx.
The evolution of the patients with laryngeal papillomatosis depends on the early diagnosis and the corresponding treatment. Material and method: using data from the literature of papillomas larynx and the clinical experience in papillomas larynx ENT Clinic in Timisoara we present actualities in the epidemiology, the diagnosis papillomas larynx the papillomas larynx in the juvenile laryngeal papillomatosis.
Conclusions: juvenile laryngeal papillomatosis is caused by papillomas larynx HPV types 6 and The treatment follows two objectives: relapses and the reestablishment of the respiratory and phonatory function.